Darmstadt, Germany

Friedrich Loebich

This inventor holds 2 USPTO granted patents. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Friedrich Loebich. Retrieved from https://idiyas.com/inventor/friedrich-loebich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Friedrich Loebich: Innovator in Anthelmintic Research

Introduction

Friedrich Loebich is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of anthelmintic research, focusing on innovative compounds that combat parasitic infections.

Latest Patents

Loebich holds 2 patents related to his work. His latest patents include an anthelmintic compound known as 2-Benzoyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline, which is effective against cestodes and trematodes, particularly when combined with a pharmaceutically acceptable carrier. Another patent involves pyrazinoisoquinolines as anthelmintic agents, specifically the compound (-)-2-Benzoyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline, which is synthesized through benzoylation or cyclization processes.

Career Highlights

Friedrich Loebich is associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he continues to advance his research in the pharmaceutical field. His work has been instrumental in developing new treatments for parasitic infections.

Collaborations

Loebich has collaborated with notable colleagues such as Rolf Pohlke and Herbert Thomas, contributing to a dynamic research environment that fosters innovation.

Conclusion

Friedrich Loebich's contributions to anthelmintic research highlight his role as a key inventor in the pharmaceutical industry. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…